| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $652K | -97.8% |
| R&D Expense | $82.9M | +46.6% |
| SG&A Expense | $21.1M | +12.6% |
| Operating Income | -$103.3M | -128.3% |
| Income Tax | $0 | — |
| Net Income | -$101.9M | -126.7% |
| EPS (Basic) | -$2.41 | -125.2% |
| EPS (Diluted) | -$2.41 | -125.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $47.4M | -48.7% |
| Current Assets | $184.6M | -36.0% |
| Total Assets | $205.3M | -31.2% |
| Current Liabilities | $25.0M | +1.5% |
| Total Liabilities | $29.2M | +8.8% |
| Stockholders' Equity | $176.2M | -35.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$94.5M | -65.4% |
| Capital Expenditures | $11.6M | +46.5% |
| Investing Cash Flow | $49.4M | +573.4% |
| Financing Cash Flow | $171K | -91.1% |
| Free Cash Flow | -$106.1M | -63.1% |